| Record ID | marc_miami_univ_ohio/allbibs0090.out:7776451:1278 |
| Source | Miami University of Ohio |
| Download Link | /show-records/marc_miami_univ_ohio/allbibs0090.out:7776451:1278?format=raw |
LEADER: 01278nam 2200277 i 4500
001 ocm04623121
008 790206s1978 dcu f00010 eng d
020 $bpbk
040 $aGPO$cGPO
043 $an-us---
049 $aMIAM
074 $a1019
086 $aY 4.In 8/4:D 84/4
086 $aY 4.In 8/4:D 84/4
110 10 $aUnited States.$bCongress.$bHouse.$bCommittee on Interstate and Foreign Commerce.$bSubcommittee on Consumer Protection and Finance
245 10 $aH.R. 1963, the substitute prescription drug act :$breport of the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session
260 0 $aWashington :$bU.S. Govt. Print. Off.,$c1978
300 $aii, 5 p. ;$c24 cm
500 $aAt head of title: 95th Congress, 2d session. Committee print. Committee print no. 95-74
500 $aDec. 1978
650 0 $aPharmacy$xLaw and legislation$zUnited States
650 0 $aDrugs$xLaw and legislation$zUnited States
740 00 $aSubstitute prescription drug act
907 $a.b21907869$b10-30-99$c11-16-94
998 $aswdep$b11-16-94$cm$da$e-$feng$gdcu$h0$i1
945 $g1$i81545100517$i35054016670214$j0$lrgstd$o-$p$0.00$s-$t19$u0$v0$w0$x0$y.i2587732x$z11-16-94